Topics

Amgen and Novartis suspend two Alzheimer’s prevention trials

19:00 EDT 11 Jul 2019 | Net Resources International

Amgen and Novartis have announced the discontinuation of two pivotal Phase II/III clinical trials conducted in alliance with Banner Alzheimer’s...
Read More...

The post Amgen and Novartis suspend two Alzheimer’s prevention trials appeared first on Drug Development Technology.

Original Article: Amgen and Novartis suspend two Alzheimer’s prevention trials

NEXT ARTICLE

More From BioPortfolio on "Amgen and Novartis suspend two Alzheimer’s prevention trials"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...